Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $111
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an 'Outperform' rating on US Physical Therapy (NYSE:USPH), but lowered the price target from $124 to $111.
November 09, 2023 | 4:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
US Physical Therapy's price target has been lowered from $124 to $111 by Barrington Research, though the 'Outperform' rating is maintained.
The lowering of the price target by Barrington Research could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside for the stock, which could counterbalance the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100